Medical device maker Medtronic Plc on Tuesday beat analysts' profit estimates for the second quarter and boosted its annual revenue growth outlook, driven by robust sales at its cardiac and surgical product units, sending its shares up 3 percent.

The European Commission said on Tuesday that it approved the $62-billion takeover of London's Shire plc by Takeda Pharmaceutical of Japan, subject to the divestment of a Shire drug in development.

Mexico's axolotl salamander can almost magically heal itself, holding the power to regrow its heart and brain. But there is one feat it may not pull off: survive dire threats to the last wild place it calls home.

Medical device maker Medtronic Plc reported a 6 percent rise in quarterly revenue on Tuesday, helped by higher sales in its cardiac and vascular business.

Here are some of the main factors that may affect Swiss stocks on Tuesday:

Mexico's axolotl salamander can almost magically heal itself, holding the power to regrow its heart and brain. But there is one feat it may not pull off: survive dire threats to the last wild place it calls home.

A vaccine to prevent infections caused by the deadly mosquito-borne Zika virus induced immune response and was found to be safe in an early stage trial, Emergent BioSolutions Inc and partner Valneva SE said on Monday.

Fortress Biotech Inc said on Monday it will sell its majority stake in the independent wealth management firm National Holdings Corp, bringing an end to an unusual ownership arrangement that had drawn scrutiny from the investing and securities industries.

Biotech incubator Fortress Biotech Inc said on Monday it would sell its majority stake in brokerage National Holdings Corp to financial services provider B Riley Financial in a deal valued at $22.9 million.

Global health authorities need to counter a worrying lull in the fight against malaria by focusing their efforts on the near-dozen mostly African countries where it claims most lives, the World Health Organization said.